Hiroyuki Seimiya

7.3k total citations
117 papers, 5.1k citations indexed

About

Hiroyuki Seimiya is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Hiroyuki Seimiya has authored 117 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 33 papers in Oncology and 26 papers in Physiology. Recurrent topics in Hiroyuki Seimiya's work include Telomeres, Telomerase, and Senescence (25 papers), RNA Interference and Gene Delivery (19 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Hiroyuki Seimiya is often cited by papers focused on Telomeres, Telomerase, and Senescence (25 papers), RNA Interference and Gene Delivery (19 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Hiroyuki Seimiya collaborates with scholars based in Japan, United States and France. Hiroyuki Seimiya's co-authors include Tetsuo Mashima, Takashi Tsuruo, T Tsuruo, Imad Naasani, Yukiko Muramatsu, Susan Smith, Tomokazu Ohishi, Toshiro Migita, Kazuo Shin‐ya and Keiji Okamoto and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hiroyuki Seimiya

114 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Seimiya Japan 37 3.9k 1.1k 1.0k 900 304 117 5.1k
Annamaria Biroccio Italy 41 3.7k 0.9× 679 0.6× 747 0.7× 1.3k 1.4× 358 1.2× 117 5.1k
Yibin Deng United States 24 2.9k 0.7× 806 0.8× 1.1k 1.1× 674 0.7× 419 1.4× 42 3.8k
Guangchao Sui United States 35 4.6k 1.2× 1.2k 1.1× 535 0.5× 862 1.0× 501 1.6× 94 6.5k
Andrei V. Budanov United States 26 4.5k 1.1× 1.0k 0.9× 570 0.6× 930 1.0× 583 1.9× 42 6.1k
Young‐Ah Suh South Korea 29 3.1k 0.8× 742 0.7× 710 0.7× 1.4k 1.6× 920 3.0× 58 4.7k
Véronique Nogueira United States 22 4.0k 1.0× 1.3k 1.2× 685 0.7× 642 0.7× 342 1.1× 34 5.3k
Eugenia V. Broude United States 28 2.7k 0.7× 457 0.4× 727 0.7× 1.8k 2.0× 280 0.9× 56 4.1k
Stéphane Rocchi France 37 2.9k 0.7× 642 0.6× 686 0.7× 1.0k 1.1× 675 2.2× 74 4.5k
Carmen Blanco‐Aparicio Spain 31 2.6k 0.6× 590 0.6× 541 0.5× 936 1.0× 379 1.2× 79 3.9k
Emanuela Felley‐Bosco Switzerland 31 1.7k 0.4× 823 0.8× 687 0.7× 708 0.8× 445 1.5× 98 3.7k

Countries citing papers authored by Hiroyuki Seimiya

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Seimiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Seimiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Seimiya more than expected).

Fields of papers citing papers by Hiroyuki Seimiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Seimiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Seimiya. The network helps show where Hiroyuki Seimiya may publish in the future.

Co-authorship network of co-authors of Hiroyuki Seimiya

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Seimiya. A scholar is included among the top collaborators of Hiroyuki Seimiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Seimiya. Hiroyuki Seimiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mashima, Tetsuo, et al.. (2024). Intratumor transforming growth factor-β signaling with extracellular matrix-related gene regulation marks chemotherapy-resistant gastric cancer. Biochemical and Biophysical Research Communications. 721. 150108–150108. 1 indexed citations
2.
Mashima, Tetsuo, Koshi Kumagai, Takeru Wakatsuki, et al.. (2024). Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer. Cancer Research Communications. 4(5). 1307–1320. 4 indexed citations
3.
Mashima, Tetsuo, et al.. (2024). BET protein–dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer. Cancer Letters. 584. 216632–216632. 4 indexed citations
4.
5.
Mashima, Tetsuo, et al.. (2020). Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase. Molecular Cancer Therapeutics. 19(3). 765–776. 17 indexed citations
6.
Ma, Yue, Sachiko Okabe, Yuki K. Wakabayashi, et al.. (2020). Target identification of a macrocyclic hexaoxazole G-quadruplex ligand using post-target-binding visualization. Chemical Communications. 56(85). 12905–12908. 16 indexed citations
7.
Muramatsu, Yukiko, et al.. (2020). A fully synthetic 6-aza-artemisinin bearing an amphiphilic chain generates aggregates and exhibits anti-cancer activities. Organic & Biomolecular Chemistry. 18(28). 5339–5343. 11 indexed citations
8.
Ma, Yue, Shogo Sasaki, Keisuke Iida, et al.. (2018). Development of G-quadruplex ligands for selective induction of a parallel-type topology. Organic & Biomolecular Chemistry. 16(40). 7375–7382. 18 indexed citations
9.
Tanaka, Noritaka, Tetsuo Mashima, Anna Mizutani, et al.. (2017). APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer. Molecular Cancer Therapeutics. 16(4). 752–762. 68 indexed citations
10.
Ohishi, Tomokazu, Haruka Yoshida, Masamichi Katori, et al.. (2017). Tankyrase-Binding Protein TNKS1BP1 Regulates Actin Cytoskeleton Rearrangement and Cancer Cell Invasion. Cancer Research. 77(9). 2328–2338. 32 indexed citations
11.
Mashima, Tetsuo, Toshiro Migita, Takeshi Yuasa, et al.. (2014). TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression. Cancer Research. 74(17). 4888–4897. 38 indexed citations
12.
Ohishi, Tomokazu, Yukiko Muramatsu, Haruka Yoshida, & Hiroyuki Seimiya. (2014). TRF1 Ensures the Centromeric Function of Aurora-B and Proper Chromosome Segregation. Molecular and Cellular Biology. 34(13). 2464–2478. 29 indexed citations
13.
Iida, Keisuke, et al.. (2013). Evaluation of the Interaction between Long Telomeric DNA and Macrocyclic Hexaoxazole (6OTD) Dimer of a G-quadruplex Ligand. Molecules. 18(4). 4328–4341. 30 indexed citations
14.
Miyazaki, Takeshi, Kaushal Joshi, Bin Hu, et al.. (2012). Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene, c-Myb. Clinical Cancer Research. 18(5). 1268–1280. 97 indexed citations
15.
Ohishi, Tomokazu, Toru Hirota, Takashi Tsuruo, & Hiroyuki Seimiya. (2010). TRF1 Mediates Mitotic Abnormalities Induced by Aurora-A Overexpression. Cancer Research. 70(5). 2041–2052. 26 indexed citations
16.
Ohishi, Tomokazu, et al.. (2010). Tankyrase‐1 assembly to large protein complexes blocks its telomeric function. FEBS Letters. 584(18). 3885–3890. 3 indexed citations
17.
Muramatsu, Yukiko, Tomokazu Ohishi, Michiko Sakamoto, Takashi Tsuruo, & Hiroyuki Seimiya. (2007). Cross‐species difference in telomeric function of tankyrase 1. Cancer Science. 98(6). 850–857. 27 indexed citations
18.
Seimiya, Hiroyuki. (2006). Cancer therapy targeting the telomere maintenance system. Drug Delivery System. 21(1). 24–31. 1 indexed citations
19.
20.
Hamada, Hirofumi, et al.. (1992). Mouse‐Human Chimeric Antibody MH171 against the Multidrug Transporter P‐Glycoprotein. Japanese Journal of Cancer Research. 83(5). 515–521. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annamaria Biroccio Breakdown of academic impact, for papers by Yibin Deng Breakdown of academic impact, for papers by Guangchao Sui Breakdown of academic impact, for papers by Andrei V. Budanov Breakdown of academic impact, for papers by Young‐Ah Suh Breakdown of academic impact, for papers by Véronique Nogueira Breakdown of academic impact, for papers by Eugenia V. Broude Breakdown of academic impact, for papers by Stéphane Rocchi Breakdown of academic impact, for papers by Carmen Blanco‐Aparicio Breakdown of academic impact, for papers by Emanuela Felley‐Bosco
Rankless by CCL
2026